Palm Vein Biometrics Market Share

Statistics for the 2023 & 2024 Palm Vein Biometrics market share, created by Mordor Intelligence™ Industry Reports. Palm Vein Biometrics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Palm Vein Biometrics Industry

The palm vein biometrics market is competitive and consists of several major players. Many companies are increasing their market presence by introducing new products, by expanding their operations or by entering into strategic mergers and acquisitions.

  • November 2019 - Fujitsu launched sales of the FUJITSU Security Solution AuthConductor V2 which uses various authentication methods, including palm vein authentication, to deliver comprehensive biometric authentication support for customers. In addition to providing a unified palm vein authentication office environment, this product features facial authentication, fingerprint authentication and IC card authentication for PC logons, and is fully scalable to support use by anywhere from several people to organizations with tens of thousands of users. With the launch of this upgraded solution, Fujitsu enables customers to enjoy convenience with secure and flexible solutions for a diverse range of use cases and authentication scenarios.
  • June 2019 - Redrock Biometrics launched its identification solution, PalmID-X. It expands the applicability of biometric identification to multiple people, creating a basis for seamless services and transactions without physical tokens. It captures palm prints and/or subdermal veins to create a unique palm signatures.

Palm Vein Biometrics Market Leaders

  1. Fujitsu Limited

  2. BioEnable Technologies Pvt Ltd

  3. M2SYS Technology - KernellÓ Inc.

  4. Mantra Softech Pvt Ltd

  5. BioSec Group Ltd

*Disclaimer: Major Players sorted in no particular order

palm vein biometrics market

Palm Vein Biometrics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)